DAP凋亡诱导蛋白激酶2抗体

Quantity size:

0.2ml

Concentration:

1mg/ml  DAP凋亡诱导蛋白激酶2抗体 Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

Background:

Apoptosis is mediated by death domain containing adapter molecules and a caspase family of proteases. Certain serine/threonine protein kinases, such as ASK1 and RIP, are mediators of apoptosis. DAP凋亡诱导蛋白激酶2抗体Two novel serine/threonine kinases that induce apoptosis were recently identified and designated DRAK1 and DRAK2 (for DAP kinase related apoptosis inducing protein kinases). DRAKs contain an N terminal kinase domain and a C terminal regulation domain. Overexpression of DRAK2 induces apoptosis. DRAKs have high sequence homology to DAP and ZIP kinases, and they represent a novel family of serine/threonine kinases, which mediates apoptosis through their catalytic activities. DAP凋亡诱导蛋白激酶2抗体DRAK2 is located in nucleus and the messenger RNA was ubiquitously expressed in human tissues.

Also known as:

DAP kinase related apoptosis inducing protein; DAP kinase related apoptosis inducing protein kinase 2; Death associated protein kinase related 2; DRAK 2; Serine/threonine kinase 17b (apoptosis inducing);DAP凋亡诱导蛋白激酶2抗体 Serine/threonine kinase 17b; Serine/threonine protein kinase 17B; STK17B; ST17B_HUMAN.

Specificity:

●

Rabbit Polyclonal IgG, affinity purified by Protein A.

●

Reacts with: Human, Mouse, Rat, Dog, Pig, Cow, Horse, Rabbit, Sheep, .

●

Immunogen: KLH conjugated synthetic peptide derived from human DRAK2.

●

DAP凋亡诱导蛋白激酶2抗体Predicted Molecular Weight: 42kDakDa.

Storage:

Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).

Application:

IHC-P=1:100-500  IHC-F=1:100-500  IF=1:100-500   
Not yet tested in other applications. 
Optimal working dilutions must be determined by the end user.

kl072Hu01防御素β2(DEFβ2)多克隆抗体Polyclonal Antibody to Defensin Beta 2 (DEFb2)

kl072Mu01防御素β2(DEFβ2)多克隆抗体Polyclonal Antibody to Defensin Beta 2 (DEFb2)

kl072Po01防御素β2(DEFβ2)多克隆抗体Polyclonal Antibody to Defensin Beta 2 (DEFb2)

kl073Bo01白介素2(IL2)多克隆抗体Polyclonal Antibody to Interleukin 2 (IL2)

kl073Ca01白介素2(IL2)多克隆抗体Polyclonal Antibody to Interleukin 2 (IL2)

kl073Cp01白介素2(IL2)多克隆抗体Polyclonal Antibody to Interleukin 2 (IL2)

kl073Eq01白介素2(IL2)多克隆抗体Polyclonal Antibody to Interleukin 2 (IL2)

kl073Ga01白介素2(IL2)多克隆抗体Polyclonal Antibody to Interleukin 2 (IL2)

kl073Gu01白介素2(IL2)多克隆抗体Polyclonal Antibody to Interleukin 2 (IL2)

kl073Hu01白介素2(IL2)多克隆抗体Polyclonal Antibody to Interleukin 2 (IL2)

kl073Mu01白介素2(IL2)多克隆抗体Polyclonal Antibody to Interleukin 2 (IL2)

kl073Po01白介素2(IL2)多克隆抗体Polyclonal Antibody to Interleukin 2 (IL2)

kl073Rb51白介素2(IL2)多克隆抗体Polyclonal Antibody to Interleukin 2 (IL2)

kl073Si01白介素2(IL2)多克隆抗体Polyclonal Antibody to Interleukin 2 (IL2)

kl075Hu01前动力蛋白受体2(PKR2)多克隆抗体Polyclonal Antibody to Prokineticin Receptor 2 (PKR2)

kl076Ca01白介素3(IL3)多克隆抗体Polyclonal Antibody to Interleukin 3 (IL3)

kl076Cp01白介素3(IL3)多克隆抗体Polyclonal Antibody to Interleukin 3 (IL3)

kl076Ga01白介素3(IL3)多克隆抗体Polyclonal Antibody to Interleukin 3 (IL3)

kl076Hu01白介素3(IL3)多克隆抗体Polyclonal Antibody to Interleukin 3 (IL3)

kl076Mu01白介素3(IL3)多克隆抗体Polyclonal Antibody to Interleukin 3 (IL3)

kl076Ra01白介素3(IL3)多克隆抗体Polyclonal Antibody to Interleukin 3 (IL3)

kl077Bo01白介素4(IL4)多克隆抗体Polyclonal Antibody to Interleukin 4 (IL4)

kl077Ca01白介素4(IL4)多克隆抗体Polyclonal Antibody to Interleukin 4 (IL4)

kl077Cp01白介素4(IL4)多克隆抗体Polyclonal Antibody to Interleukin 4 (IL4)

kl077Eq01白介素4(IL4)多克隆抗体Polyclonal Antibody to Interleukin 4 (IL4)

kl077Ga01白介素4(IL4)多克隆抗体Polyclonal Antibody to Interleukin 4 (IL4)

kl077Mu01白介素4(IL4)多克隆抗体Polyclonal Antibody to Interleukin 4 (IL4)